Pain, a multifaceted and personal sensation, has been a focal point of extensive inquiry spanning various domains such as neuroscience, psychology, and medicine. Traditionally, Euploca ovalifolia has been employed for its analgesic attributes and its capacity to promote wound healing. This study is dedicated to unraveling the analgesic potential of the methanolic extract derived from the entire Euploca ovalifolia (Forssk) plant. The effectiveness of the crude extract in providing peripheral analgesia was evaluated using a mouse model of acetic acid-induced writhing test and central analgesic activity was evaluated using tail flick method.The tail flick method was employed to assess the central analgesic effect of the crude methanolic extract obtained from Euploca ovalifolia. Remarkably, when administered at doses of 200mg/kg and 400mg/kg, the extract exhibited a highly significant analgesic effect, as indicated by a p-value of less than 0.001. This suggests that the extract effectively reduced pain sensitivity in the test subjects, signifying its potential as a therapeutic agent for pain management. The result display the central and peripheral analgesic activity of methanolic extract of Euploca ovalifolia in a dose dependent manner. These findings underscore the promising analgesic properties of the methanolic extract of Euploca ovalifolia and highlight its potential as a natural source of pain relief, warranting further investigation and exploration of its mechanisms of action. Keywords: Analgesic activity, euplocaovalifolia, methanolic extract, Diclofenac sodium,Tail flick method,Acetic acid induced writhing test.